STAT October 31, 2025
Lizzy Lawrence

Prasad is contending with slumping morale as senior leaders quit CBER

WASHINGTON — A slow-boiling feud between Vinay Prasad and his staff at the Food and Drug Administration is threatening the future of the center that regulates the nation’s vaccines, biological products, and blood supply.

Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as director, to escape a work environment that eight agency officials described to STAT as rife with mistrust and paranoia. These officials said staffers are terrified of pushing back on Prasad, lest they...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article